| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.9M | +165.4% |
| Cost of Revenue | $6.8M | -36.2% |
| Gross Profit | $4.0M | +161.2% |
| R&D Expense | $3.3M | -47.9% |
| SG&A Expense | $11.9M | -19.3% |
| Operating Income | -$52.6M | +26.0% |
| Interest Expense | $3.1M | -20.0% |
| Pre-tax Income | -$30.1M | +57.7% |
| Income Tax | -$4.7M | — |
| Net Income | -$25.4M | +66.1% |
| EPS (Basic) | -$1.18 | -53.2% |
| EPS (Diluted) | -$1.18 | -53.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -72.6% |
| Accounts Receivable | $3.4M | +120.3% |
| Inventory | $1.3M | +37.9% |
| Current Assets | $11.4M | -52.5% |
| Total Assets | $14.2M | -63.8% |
| Current Liabilities | $13.4M | -54.3% |
| Long-term Debt | $1.4M | -91.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.9M | +44.9% |
| Capital Expenditures | $133K | -50.6% |
| Investing Cash Flow | -$133K | -100.3% |
| Financing Cash Flow | $22.2M | -27.1% |
| Free Cash Flow | -$36.1M | +44.9% |
| Total Liabilities |
| $19.8M |
| -34.2% |
| Stockholders' Equity | -$5.5M | -159.8% |